ALLIED LABS LLC
NPI 1992439962
Clinical Medical Laboratory in West Monroe, LA

NPI Status: Active since July 14, 2022

Contact Information

101 N 2ND ST STE 101A
WEST MONROE, LA
ZIP 71291
Phone: (318) 884-0552
Fax: (318) 737-7245

Get Directions Write a Review

  • Organization
  • Clinical Medical Laboratory
  • CLIA Number: 19D2259819
  • CLIA Cert. Type: Independent
  • CLIA Exp. Date: 09-04-2027

About ALLIED LABS LLC

This page provides the complete NPI Profile along with additional information for Allied Labs Llc, a provider established in West Monroe, Louisiana operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1992439962 assigned on July 2022. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated 4 years ago. The authorized official of this NPI record is Dawne Smith (Ceo)

NPI
1992439962
Provider Name
ALLIED LABS LLC
Entity Type
Organization
Location Address
101 N 2ND ST STE 101A WEST MONROE, LA 71291
Location Phone
(318) 884-0552
Location Fax
(318) 737-7245
Mailing Address
101 N 2ND ST STE 101A WEST MONROE, LA 71291
Mailing Phone
(318) 884-0552
Mailing Fax
(318) 737-7245
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
07-14-2022
Last Update Date
07-14-2022
Code Navigator

Establishments like Allied Labs Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.

Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinical Medical Laboratory

Taxonomy Code
291U00000X
Type
Laboratories
Taxonomy Description
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

DAWNE SMITH

Authorized Official Title
CEO
Authorized Official Phone
(318) 372-4010

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus

This test identifies if you have COVID-19, influenza A or B, or respiratory syncytial virus. It uses a multiplex amplified probe technique, which amplifies and detects specific genetic material of the viruses, helping in accurate diagnosis.

This service was performed 16 times for 16 patients

Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique

This test checks for the presence of Chlamydia pneumoniae, a bacterium that can cause respiratory infections. It uses an amplified probe technique, which magnifies the bacterium's genetic material for easier detection. It's a standard, non-invasive procedure.

This service was performed 21 times for 21 patients

Detection test by nucleic acid for enterovirus (intestinal virus), amplified probe technique

This test identifies the presence of an enterovirus, a type of virus that primarily targets the digestive system. It uses a method called the amplified probe technique to boost the detection of the virus's genetic material, or nucleic acid.

This service was performed 21 times for 21 patients

Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique

A detection test for Legionella Pneumophila, a waterborne bacteria, uses the amplified probe technique. This involves identifying the bacteria's unique genetic material (nucleic acid) and amplifying it for easier detection, aiding in accurate diagnosis.

This service was performed 21 times for 21 patients

Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique

This test checks for Mycoplasma pneumoniae, a bacteria that can cause lung infection. It uses a method called amplified probe technique, which identifies the bacteria's genetic material. This helps in diagnosing the infection accurately.

This service was performed 21 times for 21 patients

Detection test by nucleic acid for organism, amplified probe technique

A nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.

This service was performed 1,651 times for 100 patients

Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique

A detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.

This service was performed 126 times for 99 patients

Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique

A detection test by nucleic acid for MRSA bacteria uses an amplified probe technique. It's a lab procedure that identifies the presence of MRSA, a type of bacteria resistant to many antibiotics. This test helps in deciding the best treatment.

This service was performed 127 times for 100 patients

Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique

This test detects Group A Streptococcus bacteria in your body. It uses an amplified probe technique, which amplifies the bacteria's nucleic acid, making it easier to identify. This test helps diagnose conditions like strep throat or scarlet fever.

This service was performed 126 times for 100 patients

Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique

The detection test by nucleic acid for vancomycin-resistant strep (VRE) is a laboratory procedure. It uses an amplified probe technique to identify specific genetic material in bacteria. This helps determine if the bacteria are resistant to the antibiotic vancomycin.

This service was performed 109 times for 85 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within

This is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.

This service was performed 4,500 times for 546 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r

This is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.

This service was performed 4,502 times for 546 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
19D2259819
Facility Type
Independent
Certificate Effective Date
September 05, 2025
Certificate Expiration Date
September 04, 2027
Laboratory Director
DR. MICHAEL STOUT
Certificate Type
Certificate of Accreditation
Certificate Type Description
This is a CLIA certificate is issued to Allied Labs Llc on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.

Reviews for ALLIED LABS LLC

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI NPI Number Validation

How NPI Validation Works

The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.

To verify the NPI 1992439962, we treat the final digit (2) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 78. The final step is to find the difference between that total and the next multiple of ten (80 - 78 = 2).

Digit-by-digit view

Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.

Pos 1
1
Doubled → 2
Pos 2
9
Unchanged
Pos 3
9
Doubled → 18 → 1 + 8
Pos 4
2
Unchanged
Pos 5
4
Doubled → 8
Pos 6
3
Unchanged
Pos 7
9
Doubled → 18 → 1 + 8
Pos 8
9
Unchanged
Pos 9
6
Doubled → 12 → 1 + 2
Check
2
Target digit
Regular digit Doubled digit Check digit

Step 1: Double every other digit from the right

Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.

1 → 2 9 → 18 → 9 4 → 8 9 → 18 → 9 6 → 12 → 3

Step 2: Add all digits plus the NPI constant

Add the transformed values, the unchanged digits, and the constant 24.

2 + 9 + 1 + 8 + 2 + 8 + 3 + 1 + 8 + 9 + 1 + 2 + 24 = 78

Step 3: Find the amount needed to reach the next multiple of 10

The next multiple of ten after 78 is 80. The difference is the calculated check digit.

80 - 78 = 2
This NPI is valid
The calculated check digit is 2, which matches the last digit of 1992439962.

Other Providers at the Same Location


The following 1 provider is registered at the same or a nearby location.

Clinical Medical Laboratory
101 N 2ND ST STE 101A
WEST MONROE, LA 71291

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1992439962, enumerated as an "organization" on July 14, 2022.

The provider is located at 101 N 2ND ST STE 101A WEST MONROE, LA 71291 and the phone number is (318) 884-0552.

Clinical Medical Laboratory with taxonomy code 291U00000X.